Select delivery option
You have no items in your shopping cart.
OncoSignature HT screening platform for the prediction of anticancer drug sensitivity
Category: Research Services
Cell based screens for immuno-oncology discovery research
Genetic screening with CRISPR-Cas9: Proof & Principles
Biomarker-based pooled CRISPR-Cas9 screening: Platform development and validation
CRISPR-Cas9: a tool for rapid target discovery and validation
P450 induction in cryopreserved hepatocytes from PXR and CAR nuclear receptor KO rats
Category: In Vivo Models
Genetic Toolbox for Neuroscience
Dual CRISPRi & CRISPRa screening reveals phenotypic switches in BRAF inhibition
Modelling Neurological Disease: In Vitro Gene Editing and iPSC Differentiation Combine ...
Category: Cell Lines
Modelling Familial Hypercholesterolemia Using Human Isogenic Induced Pluripotent Stem C...
CRISPR-Cas9 sensitivity and resistance screens in haploid and isogenic human cancer cel...
Low frequency variant detection from FFPE and cell-free DNA using target capture
Category: Reference Standards
Development of an in vitro screening platform for high-capacity evaluation of immunomod...
SMRT Sequencing for the Detection of Low-Frequency Somatic Variants
Genome editing in haploid human cells using CRISPR/Cas9
Using CRISPR for target identification and target validation
1-16 of 73
© 2018 Horizon Discovery Group plc, Company Registration Number 08921143